Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).
Avelumab is under clinical development by Merck and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...
Pakistani police say they have arrested the key suspect in the gang rape of a woman polio worker who was assaulted by three ...
Cyprus’ top court has ordered that the government's comptroller general be removed from his post for alleged misconduct and interferences in the works of judiciary. It's the first such ruling ...